GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Mentice AB (OSTO:MNTC) » Definitions » Capital Expenditure

Mentice AB (OSTO:MNTC) Capital Expenditure : kr-9.63 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Mentice AB Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Mentice AB's cash flow for capital expenditures for the three months ended in Mar. 2024 was kr-3.2 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was kr-9.63 Mil.


Mentice AB Capital Expenditure Historical Data

The historical data trend for Mentice AB's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mentice AB Capital Expenditure Chart

Mentice AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial -3.97 -25.34 -25.90 -13.05 -6.99

Mentice AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.75 -2.75 -0.38 -3.31 -3.18

Mentice AB Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-9.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mentice AB (OSTO:MNTC) Business Description

Traded in Other Exchanges
Address
Odinsgatan 10, Gothenburg, SWE, 411 03
Mentice AB is engaged in the provision of software and hardware simulation solutions for endovascular therapies. Its solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. It operates through three segments: System Sales, Software Licences, and Service.

Mentice AB (OSTO:MNTC) Headlines

No Headlines